Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7340635

Concept 2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
236,949,000,000 JPY
312,240,000,000 JPY
Cost of sales
72,950,000,000 JPY
151,329,000,000 JPY
Gross profit
163,999,000,000 JPY
160,911,000,000 JPY
Selling, general and administrative expenses
22,586,000,000 JPY
21,016,000,000 JPY
Operating profit (loss)
99,874,000,000 JPY
98,296,000,000 JPY
Finance costs
-3,000,000 JPY
2,000,000 JPY
Profit (loss) before tax
99,889,000,000 JPY
99,662,000,000 JPY
Income tax expense
25,488,000,000 JPY
26,161,000,000 JPY
Profit (loss)
JPY
74,401,000,000 JPY
JPY
74,401,000,000 JPY
74,401,000,000 JPY
JPY
73,500,000,000 JPY
JPY
73,500,000,000 JPY
73,500,000,000 JPY
JPY
JPY
Profit (loss) attributable to
Owners of parent
74,401,000,000 JPY
73,500,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
45.22
44.68
Diluted earnings (loss) per share
45.21
44.67

Talk to a Data Expert

Have a question? We'll get back to you promptly.